跳至主要内容
临床试验/JPRN-UMIN000010615
JPRN-UMIN000010615已完成未知

Clinical study on efficacy of alendronate infusion for pediatric osteogenesis imperfecta (including severe form) - Alendronate infusion for osteogenesis imperfecta

Tohoku University School of Medicine, Department of Pediatrics0 个研究点目标入组 10 人开始时间: 2013年4月30日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 15years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • -Patients with the following diseases which show fracture easily: Juvenile osteoporosis, hypophosphatasia, Ehlers-Danlos syndrome, Osteoporosis-pseudoglioma syndrome, Bruck syndrome. -Patients with osteogenesis imperfecta who falls under any of the following conditions shall be excluded: 1)Patients previously treated with any medical treatment including bisphosphonates 2)Patients with severe renal dysfunction 3)Patients with severe brain complication such as intracranial hemorrhage 4)Patients with congenital heart disease

研究者

发起方
Tohoku University School of Medicine, Department of Pediatrics

相似试验